Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,010,240 papers from all fields of science
Search
Sign In
Create Free Account
glucuronoxylomannan
Known as:
Glucuronomannoxylan
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Polysaccharides
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Analysis of multiple components involved in the interaction between Cryptococcus neoformans and Acanthamoeba castellanii.
Juliana Rizzo
,
P. Albuquerque
,
+4 authors
M. Rodrigues
Fungal Biology
2017
Corpus ID: 3741780
2016
2016
Evasion of Innate Immune Responses by the Highly Virulent Cryptococcus gattii by Altering Capsule Glucuronoxylomannan Structure
M. Urai
,
Y. Kaneko
,
+8 authors
Y. Miyazaki
Frontiers in Cellular and Infection Microbiology
2016
Corpus ID: 16992942
Cryptococcus neoformans causes life-threatening diseases mainly in immunosuppressed hosts such as AIDS patients; C. gattii causes…
Expand
2009
2009
The still obscure attributes of cryptococcal glucuronoxylomannan.
M. Rodrigues
,
Fernanda L. Fonseca
,
S. Frases
,
A. Casadevall
,
L. Nimrichter
Medical Mycology
2009
Corpus ID: 30297027
Glucuronoxylomannan (GXM) is the major capsular polysaccharide of Cryptococcus neoformans. It is essential for fungal virulence…
Expand
2009
2009
Interaction of triosephosphate isomerase from the cell surface of Staphylococcus aureus and α-(1→3)-mannooligosaccharides derived from glucuronoxylomannan of Cryptococcus neoformans
H. Furuya
,
R. Ikeda
Microbiology
2009
Corpus ID: 6144560
The glycolytic enzyme triosephosphate isomerase (TPI; EC 5.3.1.1) of Staphylococcus aureus is a candidate adhesion molecule for…
Expand
2007
2007
Contribution of the Mannan Backbone of Cryptococcal Glucuronoxylomannan and a Glycolytic Enzyme of Staphylococcus aureus to Contact-Mediated Killing of Cryptococcus neoformans
R. Ikeda
,
Fumito Saito
,
+4 authors
S. Kawamoto
Journal of Bacteriology
2007
Corpus ID: 42348263
ABSTRACT The fungal pathogen Cryptococcus neoformans is killed by the bacterium Staphylococcus aureus, and the killing is…
Expand
Highly Cited
2003
Highly Cited
2003
Differences in outcome of the interaction between Cryptococcus neoformans glucuronoxylomannan and human monocytes and neutrophils
C. Monari
,
C. Retini
,
+4 authors
A. Vecchiarelli
European Journal of Immunology
2003
Corpus ID: 23992188
Disseminated infections by the opportunistic yeast Cryptococcus neoformans are characterized by accumulation in tissues of…
Expand
Review
2001
Review
2001
Polysaccharides, mimotopes and vaccines for fungal and encapsulated pathogens.
L. Pirofski
Trends in Microbiology
2001
Corpus ID: 20635519
1998
1998
Assimilation of Xylose, Mannose, and Mannitol for Synthesis of Glucuronoxylomannan of Cryptococcus neoformansDetermined by 13C Nuclear Magnetic Resonance Spectroscopy
R. Cherniak
,
Eric B. O’Neill
,
S. Sheng
Infection and Immunity
1998
Corpus ID: 9098493
ABSTRACT Cryptococcus neoformans NIH 409 was cultured in a defined medium containing d-[1-13C]xylose (Xyl), d-[1-13C]mannose (Man…
Expand
Highly Cited
1995
Highly Cited
1995
Monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan enhance fluconazole efficacy
J. Mukherjee
,
M. Feldmesser
,
M. Scharff
,
A. Casadevall
Antimicrobial Agents and Chemotherapy
1995
Corpus ID: 42820715
Monoclonal antibody (MAb) 2H1, which binds to the capsular glucuronoxylomannan (GXM) of the fungus Cryptococcus neoformans…
Expand
1989
1989
Characterization of Cryptococcus neoformans capsular glucuronoxylomannan polysaccharide with monoclonal antibodies
F. Todaro-Luck
,
E. Reiss
,
R. Cherniak
,
L. Kaufman
Infection and Immunity
1989
Corpus ID: 37336898
Mice were immunized with Cryptococcus neoformans serotype A capsular glucuronoxylomannan (GXM) conjugated to bovine serum albumin…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE